"Hyperprolactinemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Descriptor ID |
D006966
|
| MeSH Number(s) |
C10.228.140.617.738.250.450 C19.700.355.600
|
| Concept/Terms |
Hyperprolactinemia- Hyperprolactinemia
- Hyperprolactinemias
- Prolactin, Inappropriate Secretion
- Inappropriate Secretion Prolactin
- Secretion Prolactin, Inappropriate
- Inappropriate Prolactin Secretion Syndrome
- Prolactin Hypersecretion Syndrome
- Hypersecretion Syndrome, Prolactin
- Syndrome, Prolactin Hypersecretion
- Hyperprolactinaemia
- Inappropriate Prolactin Secretion
- Prolactin Secretion, Inappropriate
- Secretion, Inappropriate Prolactin
|
Below are MeSH descriptors whose meaning is more general than "Hyperprolactinemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperprolactinemia".
This graph shows the total number of publications written about "Hyperprolactinemia" by people in this website by year, and whether "Hyperprolactinemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperprolactinemia" by people in Profiles.
-
Suppression of hypothalamic oestrogenic signal sustains hyperprolactinemia and metabolic adaptation in lactating mice. Nat Metab. 2025 Apr; 7(4):759-777.
-
Endoscopic Endonasal Transsphenoidal Surgery for Patients with Prolactinomas: Indications and Outcomes. World Neurosurg. 2022 12; 168:e626-e635.
-
Levosulpiride-induced Hyperprolactinemia. J Coll Physicians Surg Pak. 2020 Apr; 30(4):457.
-
Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions. Breast Cancer Res. 2018 05 19; 20(1):42.
-
Calcium and Vitamin D Supplementation in Boys with Risperidone-Induced Hyperprolactinemia: A Randomized, Placebo-Controlled Pilot Study. J Child Adolesc Psychopharmacol. 2018 03; 28(2):145-150.
-
Late endocrine effects of childhood cancer. Nat Rev Endocrinol. 2016 06; 12(6):319-36.
-
Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study. Psychoneuroendocrinology. 2015 Aug; 58:130-40.
-
A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys. J Clin Psychiatry. 2010 Mar; 71(3):338-47.
-
Aripiprazole treatment of risperidone-induced hyperprolactinemia. J Clin Psychiatry. 2009 Jul; 70(7):1058-9.
-
Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents. Pharmacogenet Genomics. 2009 May; 19(5):373-82.